The results obtained in the present work suggest that downregulation of OCT-1 expression significantly reduces migration, hypoxia resistance, response to endoplasmic reticulum stress, and drug resistance of MDA-MB231 cells and thus may be taken advantage of in developing strategies to reduce triple-negative breast cancer malignancy and chemoresistance. The gene discussed is POU2F1; the disease is triple-negative breast carcinoma.